Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 1120 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 1157 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 1161 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 1183 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 2804 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 2811 Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php on line 2824 Warning: Cannot modify header information - headers already sent by (output started at /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/gravityforms/common.php:1120) in /home/httpd/vhosts/iob.ch/progstar.org/wp-content/plugins/wp-super-cache/wp-cache-phase2.php on line 1164 Issues in quantifying atrophic macular disease using retinal autofluorescence. - ProgStar

Issues in quantifying atrophic macular disease using retinal autofluorescence.

AUTHOR(S): Sunness JS, Ziegler MD, Applegate CA.

TITLE: Issues in quantifying atrophic macular disease using retinal autofluorescence. Retina 2006, Jul-Aug, 26(6):666-672.

SOURCE

Copyright © The Ophthalmic Communications Society, Inc.